Doctors track blood clot patients to update outdated risk data
NCT ID NCT07178925
Summary
This study aims to better understand how often dangerous blood clots return in people with antiphospholipid syndrome, a rare autoimmune condition. Researchers will follow 200 patients over time to track their health outcomes and identify factors that increase recurrence risk. The goal is to gather modern, accurate data to help design better future treatments for this complex condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIPHOSPHOLIPID SYNDROME (APS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University hospital of Rouen
RECRUITINGRouen, 76031, France
Conditions
Explore the condition pages connected to this study.